122例肝癌合并门脉癌栓的综合治疗与单纯TACE治疗效果比较

目的:研究肝癌合并门脉癌栓综合治疗的效果。方法:122例肝癌分为2组:A组(72例)行肝动脉化疗栓塞(TACE);B组(50例)行TACE结合外放射治疗。结果:A组1、2年生存率分别为22.3％、4.5％,平均生存期7.5个月;B组1、2、3年生存率分别为39.2%、21.2%、13.5%,平均生存期17.5个月,P<0.05。结论:对合并门脉癌栓的肝癌综合治疗能明显提高治疗效果。

The Effect Comparision of Combination Treatment with TACE in 122 Cases of Hepatocellular Carcinoma Complicated with Portal Vein Tumor Thrombus

Objective:To investigate the combination treatment effect in patients with hepatocellula carcinoma (HCC) complicated with portal vein tumor thrombus. Methods: 122 cases of HCC were divided into two groups: 72 cases were treated by transcatheter artery chemotherapy embolization (TACE)(group A) ;50 cases were treated by TACE combined with exterior radiate treatment (group B). Results: In group A the survival rates of 1 and 2 years were 22.3 % and 4.5%, respectively, and the average survival time was 7.5 months and in group B the survival rates of 1,2 and 3 years were 39.2% ,21.2% and 13 .5% ,respectively,and the average survival time was 17.5 months ( P < 0.05 ) . Conclusion: The combination treatment can obviously improve the treatment effect of HCC complicated with portal vein tumor thrombus.